Major histocompatibility complex class II molecule (MHC class II)

The major histocompatibility complex class II molecule (MHC-II) is a membrane-bound glycoprotein found primarily on professional antigen-presenting cells such as dendritic cells, macrophages, and B lymphocytes. Its main function is to present processed peptides derived from extracellular proteins ("exogenous antigens") on the cell surface for recognition by CD4+ helper T lymphocytes. This interaction is essential for initiating adaptive immune responses against pathogens and maintaining self-tolerance. Structurally, each MHC-II molecule consists of two non-identical polypeptide chains—an alpha chain and a beta chain—that together form an open-ended peptide-binding groove capable of accommodating longer peptides than those presented by MHC-I molecules[2][3][5]. Expression is tightly regulated at both transcriptional and post-translational levels; it can be induced by interferon-gamma during inflammation or infection[2][3]. Dysregulation contributes significantly to autoimmune diseases such as type I diabetes mellitus due to aberrant self-antigen presentation leading to inappropriate immune activation[3]. In summary: *The phrase "antigen presentation via major histocompatibility complex class II molecule" refers not to one discrete druggable target but rather an essential biological process mediated by the family of MHC-II proteins.*

Other names

MHC-IIHuman leukocyte antigen class II (HLA class II)HLA-DR, HLA-DP, HLA-DQ (human isoforms)

For drugs that modulate this pathway: Inhibition or modulation of antigen processing/presentation to reduce autoimmune activation. Enhancement for vaccine adjuvants or cancer immunotherapy by increasing antigen display.